
536127428 | MAAH | 05601140 | | 8905957 | 12/10/2005 12:00:00 AM | CHF , URI | | DIS | Admission Date: 12/10/2005 Report Status:

Discharge Date: 4/20/2005
****** FINAL DISCHARGE ORDERS ******
KOVALCHIK , JUDE D. 045-43-50-4
Burb , Kansas 45005
Service: MED
DISCHARGE PATIENT ON: 4/4/05 AT 04:00 PM
CONTINGENT UPON Not Applicable
WILL D/C ORDER BE USED AS THE D/C SUMMARY: YES
Attending: CINCOTTA , SHIRLEY W. , M.D. , M.PH.
CODE STATUS:
Full code
DISPOSITION: Home
DISCHARGE MEDICATIONS:
ENTERIC COATED ASPIRIN ( ASPIRIN ENTERIC COATED )
81 MG PO QD
LASIX ( FUROSEMIDE ) 100 MG PO QD
INSULIN NPH HUMAN 17 UNITS QAM; 7 UNITS QPM SC
17 UNITS QAM 7 UNITS QPM
AFRIN NASAL SPRAY ( OXYMETAZOLINE HCL )
2 SPRAY NA BID X 3 DAYS.
SALINE NASAL DROP ( SODIUM CHLORIDE 0.65% ) 2 SPRAY NA QID
PRN Other:congestion
MVI THERAPEUTIC W/MINERALS ( THERAP VITS/MINERALS )
1 TAB PO QD
Alert overridden: Override added on 6/12/05 by
GRAMBLING , JOAN , M.D.
POTENTIALLY SERIOUS INTERACTION: SIMVASTATIN & NIACIN ,
VIT. B-3 Reason for override: ok
TOPROL XL ( METOPROLOL SUCCINATE EXTENDED RELEASE )
50 MG PO QD Food/Drug Interaction Instruction
Take consistently with meals or on empty stomach.
Number of Doses Required ( approximate ): 1
SUDAFED 12HR ( PSEUDOEPHEDRINE CONTROLLED RELEASE )
120 MG PO Q12H X 5 Days Starting Today ( 8/27 )
TRAVATAN 1 DROP OS QHS
GLUCOPHAGE ( METFORMIN ) 500 MG PO BID
KCL SLOW RELEASE 20 MEQ PO QD Instructions: Take M , W , F
As per SMC Potassium Chloride Policy:
each 20 mEq dose to be given with 4 oz of fluid
Alert overridden: Override added on 4/4/05 by :
POTENTIALLY SERIOUS INTERACTION: LISINOPRIL & POTASSIUM
CHLORIDE Reason for override: ok
LIPITOR ( ATORVASTATIN ) 10 MG PO QD
Alert overridden: Override added on 4/4/05 by :
POTENTIALLY SERIOUS INTERACTION: NIACIN , VIT. B-3 &
ATORVASTATIN CALCIUM Reason for override: ok
NTG 1/150 ( NITROGLYCERIN 1/150 ( 0.4 MG ) )
1 TAB SL Q5MIN X 3 doses PRN Chest Pain
PRINIVIL ( LISINOPRIL ) 10 MG PO QD
Alert overridden: Override added on 4/4/05 by :
POTENTIALLY SERIOUS INTERACTION: POTASSIUM CHLORIDE &
LISINOPRIL
POTENTIALLY SERIOUS INTERACTION: POTASSIUM CHLORIDE &
LISINOPRIL
POTENTIALLY SERIOUS INTERACTION: POTASSIUM CHLORIDE &
LISINOPRIL Reason for override: ok
DIET: House / ADA 1800 cals/dy
ACTIVITY: Resume regular exercise
FOLLOW UP APPOINTMENT( S ):
Dr Rimi GONH cardiology 9/26 @ 3:OO ,
Trey Mione , Heart Failure Clinic 6/10 3:30 ,
Please call Dr. Florentino Depeyster at 039-178-5937 to schedule a follow-up appointment in the next 1-2 weeks. The office will re-open on 2/5/06 .  ,
ALLERGY: NKA
ADMIT DIAGNOSIS:
CHF
PRINCIPAL DISCHARGE DIAGNOSIS ;Responsible After Study for Causing Admission )
CHF , URI
OTHER DIAGNOSIS;Conditions , Infections , Complications , affecting Treatment/Stay
HTN , LAD stent , IDDM , CHF , ischemic CMP with EF 25-30%
OPERATIONS AND PROCEDURES:
none.
OTHER TREATMENTS/PROCEDURES ( NOT IN O.R. )
none.
BRIEF RESUME OF HOSPITAL COURSE:
ID/HPI:
82F w with known h/o ischemic CMP( EF 25-30% ) CAD s/p
stent & diastolic dysfunction who presents with worsening SOB X 6-8
weeks. She reports increased DOE , PND , orthopnea , denies LE swelling.
She had increased SOB on the evening prior to admission. Sh also had
intermittent chest discomfort she believes was 2/2 to her
cough. She admits to nasal congestion for the past month as well as a
nonproductive cough. No , palpitations , syncope , or
known change in weight. No fevers , chills or rash. No recent cahnge in
medications , dietary indiscretion , episodes of
HTN , or dehydration.
In the ED her vital signs were Afeb , pulse 106 , bp 100/60 , SaO2 97% 2L.
Her exam was significant for: a well-appearing woman , crackles as
the lung bases b/l , RRR , nl S1 , S2 , JVP 15cm , Abdomen was benign and the
lower extremities had trace edema. She received lasix 120iv ,
followed by 100iv with 400cc + of urine output. Her labs were
significant for Cr 1.1 , BNP 473 , and one set of negative cardiac ezymes.
EKG: sinus tachycardia w/ old LBBB/LAFB. prolonged QTc
CXR: b/l effusions , calcified aortic knowb , prominent vasculature ,
chronic interstitial markings.
IMPRESSION: CHF exacerbation with volume overload and no clear initial
precipitant.
HOSPITAL COURSE
1 ) CV: ISCHEMIA - Patient was ruled out for a myocardial infarction.
She had three sets of negative cardiac enzymes. Her EKG showed normal
sinus rhythm , left axis deviation and LBBB , findings that were unchanged
from previous EKG's. There were no findings characteristic of new
cardiac ischemia. The patient was continued on ASA 325mg , Lisinopril 10mg
qd and Simvastatin 20mg po.
PUMP - Patient has history of CHF , with an EF 25-30%. Her history and
exam were consistent with mild CHF. Her BNP was 473. The patient's wt from
previous d/c summary was 66kg. The goal total body balance was neg 1 liters
each day. The patient was given Lasix 200po qd with IV lasix as needed. Her
weight on discharge was 63 kg and she improved clinically. Patient was
started on a beta-blocker given her CAD and CHF. The patient was seen by
Antwan Heinsohn in the heart failure clinic and will follow up with her as well
as with Dr. Landrey in Cardiology.
RHYTHM - NSR , with LBBB. No acute changes.
2 ) ENDO: The patient was maintained on her home regiment of NPH 17/7 ,
Metformin 500mg bid was held given CrCl 33. A Novolog SS was also used.
FSBS were checked. The patient will be restarted on her Metformin and home
insulin regimen for discharge , but the in-patient team reccomends that her
oral hypoglycemics be re-examined given her reduced CrCl.
3 ) ID: WBC mildy elevated at 10.7 on admission. UA was dirty and a
urine culture was sent and pending at the time of discharge. No
dysuria. CXR with no infiltrate. Patient discharged with decongestants and
nasal steroid spray for URI symptoms.
4 ) PULM: SOB most likely secondary to CHF. No acute issues besides URI
sxs.
6 ) FEN: Low salt , cardiac , diabetic diet. Patient fluid restricted to
2L/day. Her electrolytes were monitored daily , given her diureses , and
replaced as
needed. Cr stable at 1.1.
7 ) PROPHYLAXIS: Lovenox 40mg/Esomeprazole 40mg po qd.
8 ) FULL CODE
ADDITIONAL COMMENTS: Please increase your lasix to 100 mg each day.
Start Toprol XL 50 mg for your blood pressure and heart failure.
Take Sudafed for 5 days and use Afrin spray for three days for nasal
congestion. Use saline spray as needed for nasal congestion.
Followup with Dr. Rutland in cardiology and with Lincoln Pasquino in the heart
failure clinic as scheduled. Also , please call Dr. Vanostrand to schedule a
follow-up appointment in the next 1-2 weeks.
DISCHARGE CONDITION: Stable
TO DO/PLAN:
Follow-up with cardiology and with the heart failure clinic as
scheduled.
No dictated summary
ENTERED BY: GEHRLEIN , BARRY T. , M.D. ( EI26 ) 4/4/05 @ 06:26 PM
****** END OF DISCHARGE ORDERS ******